Joint with: Adipose Tissue: From Cellular Mechanisms to Systemic Health
Incretin Biology and Therapeutics: Transforming Obesity and Associated Diseases

Mar 21–24, 2027 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Zach Gerhart-Hines, Richard D DiMarchi, and Fiona M. Gribble

  In Person
  On Demand
×

-

Mar 21–24, 2027 | Fairmont Banff Springs, Banff, AB, Canada

Scientific Organizers: Zach Gerhart-Hines, Richard D DiMarchi, and Fiona M. Gribble

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:   = In Person     = On Demand
Sunday, March 21, 2027
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, March 22, 2027
Breakfast
7:00–8:00 AM
Welcome and Keynote Session (Joint)
8:00–9:30 AM
Daniel J. Drucker, Lunenfeld-Tanenbaum Research Institute
Incretin Overview; MoA to Weight Control and Benefits to Other Common Associated Diseases
Philipp E. Scherer, University of Texas Southwestern Medical Center
Role of Adipose Tissue in Incretin-Based Therapeutics
Coffee Break
9:30–9:50 AM
Incretins and Adipose Tissue Biology (Joint)
9:30–11:15 AM
Jeffrey M. Friedman †, Rockefeller University
Integration of Hedonic and Homeostatic Weight Control
Samuel Klein, Washington University School of Medicine
Metabolic Adaptations to Weight Loss and Regain
Short Talk(s) Chosen from Abstracts
Meet the Editors (Joint)
11:15–12:15 PM
Poster Setup
12:15–1:00 PM
On Own for Lunch
12:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: New Advances in Incretins or Novel MoAs with Therapeutic Potential
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Peripheral versus Central Incretin Action on Homeostasis
5:00–7:00 PM
Timo D Müller, Helmholtz Munich
GIP Agonism in the Brain and Periphery
Murielle M Véniant-Ellison †, Amgen Inc.
GIP Antagonism as a Therapeutic Approach
Speaker to be Announced
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Tuesday, March 23, 2027
Breakfast
7:00–8:00 AM
Emerging Insights into Adipose Tissue and Incretin Pharmacology (Joint)
8:00–11:00 AM
Ruth E. Gimeno †, Eli Lilly and Company
Incretin Therapies for Combating Neurodegeneration and Addiction
Matthias Blüher, University of Leipzig
Novel Horizons for Liver and Kidney Health: Translating Incretin Research into Organ-Specific Therapies
Silvia Corvera, University of Massachusetts Medical School
Therapeutic Targeting of Adipose Depots
Tore Bengtsson †, Stockholm University
sing Highly Selective β2-Agonists for the Treatment of Obesity, Diabetes and Age-Related Muscle Loss
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Panel Discussion: The Future of Incretin Therapeutics: Scientific Impact, Clinical Challenge (Joint)
11:00–12:00 PM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Gut-Brain Signaling in Food Preference, Satiety, and Behavior
5:00–7:00 PM
Fiona M. Gribble, University of Cambridge
Endocrine Signaling in the Gut-Brain Axis
Lora K. Heisler †, Rowett Institute, University of Aberdeen
Uncovering Nonaversive Brain Circuits that Control Feeding
Henning Fenselau, University of Cologne
Homeostatic Feeding Circuits
Amber L. Alhadeff, Monell Chemical Senses Center
Neural Circuits Regulating Food Intake and Motivation
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, March 24, 2027
Breakfast
7:00–8:00 AM
Beyond Incretins - Newer Players
8:00–11:00 AM
Richard D DiMarchi, Indiana University
Chemistry to Enable Greater Efficacy, Safety, and Convenience
Paul M. Titchenell, Eli Lilly
Clinical Development of Targets for Lean Mass Preservation
Kirsten Raun †, Novo Nordisk A/S
Amylin Mono- and Polyagonists for Metabolic Diseases
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Beyond Incretins – Unmet Therapeutic Needs
5:00–6:45 PM
Zach Gerhart-Hines, University of Copenhagen
Energy Expenditure Targets
Katrin J. Svensson, Stanford University
Novel Peptide Discovery for Cardiometabolic Therapies
Ania Jastreboff †, Yale University
Clinical Perspective of Unmet Needs
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, March 25, 2027
Departure
12:00–11:59 PM

Subscribe for Updates